Pharmacological characterization of RS 25259‐197, a novel and selective 5‐HT3 receptor antagonist, in vivo
暂无分享，去创建一个
R. Eglen | W. Smith | R. Clark | C. Lee | R. Whiting | L. Johnson | C-H. Lee | S. Hegde | W. Smith | R. D. Clark | R. L. Whiting | C. H. Lee | W. L. Smith | L. Johnson